INIS
production
100%
antigens
100%
humans
100%
tumors
100%
stimuli
100%
delivery
100%
dendrites
100%
maturation
100%
messenger-rna
15%
surfaces
15%
secretion
15%
in vitro
10%
comparative evaluations
10%
signals
10%
molecules
10%
ligands
10%
rna
10%
proteins
5%
cancer
5%
in vivo
5%
peptides
5%
increasing
5%
clinical trials
5%
induction
5%
vaccines
5%
stimulation
5%
clone cells
5%
matrices
5%
monocytes
5%
melanomas
5%
influenza
5%
Medicine and Dentistry
Immunogenicity
100%
Dendritic Cell
100%
Maturation
100%
Tumor Antigen
100%
T Cell
33%
Antigen Specificity
22%
Messenger RNA
16%
Antigen Presentation
16%
Secretion (Process)
16%
Cell Surface
11%
In Vitro
11%
Assay
11%
Genetic Transfection
11%
RNA
11%
CD40 Ligand
11%
Development
5%
Clinical Trial
5%
Aptitude
5%
Stimulation
5%
Peptide
5%
CD8 Antigen
5%
Cell Maturation
5%
Cancer Treatment
5%
Cell Surface Marker
5%
Monocyte
5%
Influenza
5%
Matrix Protein
5%
Dendritic Cell Vaccine
5%
Melanoma Antigen
5%
Melan A
5%
Immunology and Microbiology
Immunogenicity
100%
Dendritic Cell
100%
Maturation
100%
Tumor Antigen
100%
T Cell
27%
Antigen Specificity
22%
Secretion (Process)
16%
Antigen Presentation
16%
Molecule
11%
Cell Surface
11%
Genetic Transfection
11%
CD40 Ligand
11%
Development
5%
Aptitude
5%
Cell Clone
5%
CD8
5%
CD86
5%
CD80
5%
Cell Maturation
5%
Influenza
5%
Monocyte
5%
Naive T Cell
5%
Matrix Protein
5%
Melan A
5%
Dendritic Cell Vaccine
5%
Melanoma Antigen
5%
Cell Surface Marker
5%
Keyphrases
Sequential Delivery
100%
MART
21%
M1 Matrix Protein
14%
First Maturation
7%
Optimal Mean
7%
Sequential Addition
7%